Johnson Financial Group, Inc. Exact Sciences Corp Transaction History

Johnson Financial Group, Inc.

$2.19 Billion
Q3 2024

A detailed history of Johnson Financial Group, Inc. transactions in Exact Sciences Corp stock. As of the latest transaction made, Johnson Financial Group, Inc. holds 235 shares of EXAS stock, worth $13,959. This represents 0.0% of its overall portfolio holdings.

Number of Shares

235

Previous 349 32.66%

Holding current value

$13,959

Previous $14,000 14.29%

% of portfolio

0.0%

Previous 0.0%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$42.43 - $70.83 $4,837 - $8,074	-114 Reduced 32.66%	235 $16,000
Q2 2024 Aug 14, 2024	BUY	$41.33 - $74.26 $7,728 - $13,886	187 Added 115.43%	349 $14,000
Q1 2024 May 14, 2024	SELL	$56.27 - $73.77 $289,058 - $378,956	-5,137 Reduced 96.94%	162 $11,000
Q4 2023 Feb 09, 2024	BUY	$59.06 - $75.72 $294,945 - $378,145	4,994 Added 1637.38%	5,299 $392,000
Q3 2023 Nov 14, 2023	SELL	$65.94 - $99.04 $41,410 - $62,197	-628 Reduced 67.31%	305 $20,000
Q2 2023 Aug 14, 2023	SELL	$62.68 - $95.05 $49,203 - $74,614	-785 Reduced 45.69%	933 $87,000
Q1 2023 May 12, 2023	SELL	$47.19 - $70.77 $36,336 - $54,492	-770 Reduced 30.95%	1,718 $116,000
Q3 2022 Nov 14, 2022	SELL	$31.97 - $49.37 $14,993 - $23,154	-469 Reduced 15.86%	2,488 $86,000
Q2 2022 Aug 15, 2022	SELL	$35.61 - $76.23 $13,104 - $28,052	-368 Reduced 11.07%	2,957 $117,000
Q1 2022 May 16, 2022	SELL	$57.56 - $82.54 $80,296 - $115,143	-1,395 Reduced 29.56%	3,325 $232,000
Q3 2021 Nov 12, 2021	SELL	$90.24 - $124.05 $9,024 - $12,405	-100 Reduced 2.07%	4,720 $451,000
Q2 2021 Aug 13, 2021	SELL	$93.66 - $139.27 $20,605 - $30,639	-220 Reduced 4.37%	4,820 $599,000
Q1 2021 May 14, 2021	BUY	$116.57 - $155.01 $19,000 - $25,266	163 Added 3.34%	5,040 $664,000
Q4 2020 Feb 12, 2021	SELL	$99.61 - $142.12 $24,902 - $35,530	-250 Reduced 4.88%	4,877 $646,000
Q3 2020 Nov 12, 2020	SELL	$72.92 - $102.01 $12,177 - $17,035	-167 Reduced 3.15%	5,127 $522,000
Q1 2020 May 14, 2020	BUY	$37.9 - $104.44 $9,550 - $26,318	252 Added 5.0%	5,294 $307,000
Q4 2019 Feb 14, 2020	SELL	$77.66 - $99.74 $18,250 - $23,438	-235 Reduced 4.45%	5,042 $466,000
Q3 2019 Nov 12, 2019	BUY	$90.37 - $122.49 $10,844 - $14,698	120 Added 2.33%	5,277 $477,000
Q2 2019 Aug 09, 2019	BUY	$89.51 - $118.04 $26,853 - $35,412	300 Added 6.18%	5,157 $609,000
Q1 2019 May 13, 2019	BUY	$61.98 - $96.5 $17,664 - $27,502	285 Added 6.23%	4,857 $421,000
Q1 2018 May 07, 2018	SELL	$39.82 - $57.53 $1,592 - $2,301	-40 Reduced 0.87%	4,572 $184,000
Q4 2017 Feb 12, 2018	SELL	$46.49 - $60.51 $11,622 - $15,127	-250 Reduced 5.14%	4,612 $242,000
Q3 2017 Nov 09, 2017	BUY	$37.05 - $47.12 $180,137 - $229,097	4,862	4,862 $229,000

Others Institutions Holding EXAS

# of Institutions

673

Shares Held

162M

Call Options Held

2.58M

Put Options Held

2.19M

View Full List

About EXACT SCIENCES CORP

Ticker EXAS
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 176,960,000
Market Cap $10.5B
Description
Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...

More about EXAS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Johnson Financial Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Johnson Financial Group, Inc. with notifications on news.

Account

Johnson Financial Group, Inc. Exact Sciences Corp Transaction History